CO6150152A2 - Composicion farmaceutica - Google Patents
Composicion farmaceuticaInfo
- Publication number
- CO6150152A2 CO6150152A2 CO09007492A CO09007492A CO6150152A2 CO 6150152 A2 CO6150152 A2 CO 6150152A2 CO 09007492 A CO09007492 A CO 09007492A CO 09007492 A CO09007492 A CO 09007492A CO 6150152 A2 CO6150152 A2 CO 6150152A2
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutically acceptable
- acceptable salts
- pharmaceutical composition
- saredutant
- association
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 9
- 150000003839 salts Chemical class 0.000 abstract 14
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 8
- PGKXDIMONUAMFR-AREMUKBSSA-N saredutant Chemical compound C([C@H](CN(C)C(=O)C=1C=CC=CC=1)C=1C=C(Cl)C(Cl)=CC=1)CN(CC1)CCC1(NC(C)=O)C1=CC=CC=C1 PGKXDIMONUAMFR-AREMUKBSSA-N 0.000 abstract 8
- 229950004387 saredutant Drugs 0.000 abstract 8
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 abstract 3
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 abstract 3
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 2
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 abstract 2
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 2
- 229960001653 citalopram Drugs 0.000 abstract 2
- 229960004341 escitalopram Drugs 0.000 abstract 2
- WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 abstract 2
- 229960002464 fluoxetine Drugs 0.000 abstract 2
- 229960002296 paroxetine Drugs 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 229960002073 sertraline Drugs 0.000 abstract 2
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 abstract 2
- 229960004038 fluvoxamine Drugs 0.000 abstract 1
- CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 abstract 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 1
- 229940127221 norepinephrine reuptake inhibitor Drugs 0.000 abstract 1
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 abstract 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
1.- Composiciones farmacéuticas que contienen en asociación saredutant o una de sus sales aceptables farmacéuticamente con un inhibidor selectivo de la recaptación de serotonina o con un inhibidor de la recaptación de serotonina/norepinefrina, así como al menos un excipiente aceptable farmacéuticamente. 2.- Composición farmacéutica según la reivindicación 1 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con un inhibidor selectivo de la recaptación de serotonina, así como al menos un excipiente aceptable farmacéuticamente. 3.- Composición farmacéutica según la reivindicación 1 o la reivindicación 2 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con un inhibidor selectivo de la recaptación de serotonina elegido entre fluoxetina, citalopram, escitalopram, paroxetina, sertralina y fluvoxamina, o una de sus sales aceptables farmacéuticamente así como al menos un excipiente aceptable farmacéuticamente. 4.- Composición farmacéutica según la reivindicación 3 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con fluoxetina o una de sus sales aceptables farmacéuticamente, así como al menos un excipiente aceptable farmacéuticamente. 5.- Composición farmacéutica según la reivindicación 3 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con citalopram o una de sus sales aceptables farmacéuticamente, así como al menos un excipiente aceptable farmacéuticamente. 6.- Composición farmacéutica según la reivindicación 3 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con escitalopram o una de sus sales aceptables farmacéuticamente, así como al menos un excipiente aceptable farmacéuticamente. 7.- Composición farmacéutica según la reivindicación 3 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con paroxetina o una de sus sales aceptables farmacéuticamente, así como al menos un excipiente aceptable farmacéuticamente. 8.- Composición farmacéutica según la reivindicación 3 que contiene en asociación saredutant o una de sus sales aceptables farmacéuticamente con sertralina o una de sus sales aceptables farmacéuticamente, así como al menos un excipiente aceptable farmacéuticamente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0607050A FR2904221B1 (fr) | 2006-07-31 | 2006-07-31 | Composition pharmaceutique contenant en association le saredutant et la fluoxetine. |
| FR0700863A FR2912057B1 (fr) | 2007-02-07 | 2007-02-07 | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6150152A2 true CO6150152A2 (es) | 2010-04-20 |
Family
ID=39001699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09007492A CO6150152A2 (es) | 2006-07-31 | 2009-01-28 | Composicion farmaceutica |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20080033014A1 (es) |
| EP (1) | EP2049093A2 (es) |
| JP (1) | JP2009545573A (es) |
| KR (1) | KR20090034368A (es) |
| AR (1) | AR062142A1 (es) |
| AU (1) | AU2007283530A1 (es) |
| BR (1) | BRPI0714862A2 (es) |
| CA (1) | CA2658614A1 (es) |
| CL (1) | CL2007002217A1 (es) |
| CO (1) | CO6150152A2 (es) |
| CR (1) | CR10579A (es) |
| EA (1) | EA200970167A1 (es) |
| EC (1) | ECSP099093A (es) |
| GT (1) | GT200900018A (es) |
| IL (1) | IL196570A0 (es) |
| MA (1) | MA30645B1 (es) |
| MX (1) | MX2009001219A (es) |
| NO (1) | NO20090924L (es) |
| PE (1) | PE20080431A1 (es) |
| TN (1) | TN2009000008A1 (es) |
| TW (1) | TW200817003A (es) |
| UY (1) | UY30517A1 (es) |
| WO (1) | WO2008017753A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
| EP2699539B1 (en) * | 2011-04-21 | 2019-03-06 | Emory University | Cyclopropyl derivatives and methods of use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| NL7503310A (nl) * | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| FR2508035A1 (fr) * | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| US4902710A (en) * | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
| AU4918796A (en) * | 1995-02-10 | 1996-08-27 | Eli Lilly And Company | Methods of treating or preventing psychiatric disorders |
| FR2792835B3 (fr) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression |
| AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
| WO2007047576A1 (en) * | 2005-10-14 | 2007-04-26 | The Board Of Trustees Of The University Of Illinois | Pharmacological treatments for sleep disorders |
| FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
-
2007
- 2007-07-23 TW TW096126788A patent/TW200817003A/zh unknown
- 2007-07-26 PE PE2007000979A patent/PE20080431A1/es not_active Application Discontinuation
- 2007-07-30 JP JP2009522301A patent/JP2009545573A/ja not_active Withdrawn
- 2007-07-30 AR ARP070103357A patent/AR062142A1/es unknown
- 2007-07-30 BR BRPI0714862-3A patent/BRPI0714862A2/pt not_active Application Discontinuation
- 2007-07-30 CA CA002658614A patent/CA2658614A1/fr not_active Abandoned
- 2007-07-30 EA EA200970167A patent/EA200970167A1/ru unknown
- 2007-07-30 KR KR1020097002031A patent/KR20090034368A/ko not_active Application Discontinuation
- 2007-07-30 EP EP07823369A patent/EP2049093A2/fr not_active Withdrawn
- 2007-07-30 CL CL200702217A patent/CL2007002217A1/es unknown
- 2007-07-30 US US11/830,325 patent/US20080033014A1/en not_active Abandoned
- 2007-07-30 AU AU2007283530A patent/AU2007283530A1/en not_active Abandoned
- 2007-07-30 WO PCT/FR2007/001314 patent/WO2008017753A2/fr active Application Filing
- 2007-07-30 MX MX2009001219A patent/MX2009001219A/es not_active Application Discontinuation
- 2007-07-31 UY UY30517A patent/UY30517A1/es not_active Application Discontinuation
-
2009
- 2009-01-14 TN TN2009000008A patent/TN2009000008A1/fr unknown
- 2009-01-18 IL IL196570A patent/IL196570A0/en unknown
- 2009-01-21 CR CR10579A patent/CR10579A/es not_active Application Discontinuation
- 2009-01-27 EC EC2009009093A patent/ECSP099093A/es unknown
- 2009-01-28 CO CO09007492A patent/CO6150152A2/es unknown
- 2009-02-13 MA MA31638A patent/MA30645B1/fr unknown
- 2009-02-27 NO NO20090924A patent/NO20090924L/no not_active Application Discontinuation
- 2009-05-20 US US12/469,215 patent/US20090227632A1/en not_active Abandoned
- 2009-07-31 GT GT200900018A patent/GT200900018A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA30645B1 (fr) | 2009-08-03 |
| CL2007002217A1 (es) | 2008-03-07 |
| IL196570A0 (en) | 2009-11-18 |
| US20080033014A1 (en) | 2008-02-07 |
| CR10579A (es) | 2009-03-20 |
| AR062142A1 (es) | 2008-10-15 |
| KR20090034368A (ko) | 2009-04-07 |
| TW200817003A (en) | 2008-04-16 |
| GT200900018A (es) | 2010-08-23 |
| NO20090924L (no) | 2009-03-18 |
| JP2009545573A (ja) | 2009-12-24 |
| CA2658614A1 (fr) | 2008-02-14 |
| EP2049093A2 (fr) | 2009-04-22 |
| ECSP099093A (es) | 2009-02-27 |
| PE20080431A1 (es) | 2008-05-26 |
| AU2007283530A1 (en) | 2008-02-14 |
| WO2008017753A2 (fr) | 2008-02-14 |
| UY30517A1 (es) | 2008-02-29 |
| BRPI0714862A2 (pt) | 2013-07-02 |
| MX2009001219A (es) | 2009-02-13 |
| EA200970167A1 (ru) | 2009-08-28 |
| TN2009000008A1 (en) | 2010-08-19 |
| US20090227632A1 (en) | 2009-09-10 |
| WO2008017753A3 (fr) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160454T1 (hr) | Kombinacija spoja morfinana i antidepresiva za liječenje pseudobulbarnog afekta | |
| CU20080235A7 (es) | Composiciones farmacéuticas estabilizadas que comprenden fesoterodina | |
| IL216247A0 (en) | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
| ECSP055885A (es) | Derivados de carbostirilo e inhibidores de la recaptacion de serotonina que sirven para el tratamiento de desordenes en el humor | |
| CO6361993A2 (es) | Compuestos de 4-[2-(2-fluorofenoximetil)fenil]piperidina | |
| NO20091395L (no) | Nye tiofenderivater | |
| RS52676B (en) | 4- [2- (4-METHYLPHENYLSULPHANYL) PHENYL] PIPERIDINE WITH COMBINED SEROTONINE AND NOREPINEPHRINE REHIBITION FOR THE TREATMENT OF ADHD, MELANCHOLIA, TREATMENT-RESISTANT DISPOSAL, OR SIMPRESSION | |
| HRP20120713T1 (hr) | Kombinacija analeptičkog modafinila i antidepresiva za liječenje depresije | |
| BRPI0606881A2 (pt) | composto derivado de dihidroimidazotiazol, composição farmacêutica, seu uso e processo para a sua produção | |
| AR055062A1 (es) | Base cristalina de escitalopram y comprimidos bucodispersables que comprenden una base de escitalopram | |
| JP2012036212A5 (es) | ||
| CO6150152A2 (es) | Composicion farmaceutica | |
| EA201170100A1 (ru) | Алканолпиперазиновые производные бензотиофена и их применение в качестве антидепрессанта | |
| CL2009000261A1 (es) | Imidazolin-2,4 dionas metil fenoxi sustituidas, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y a la nicotina. | |
| CL2013001345A1 (es) | Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano-4-sustituidos, antagonistas del receptor mglur 2/3; composicion farmaceutica que comprende uno de estos compuestos; y composicion farmaceutica que comprende uno de estos compuestos y un inhibidor de la reabsorcion de serotonina, tal como fluoxetina o citalopram. | |
| CL2009000259A1 (es) | Imidazolin-2,4 dionas sustituidas con arilo, composicion farmaceutica que contenga estos compuestos y su uso en el sindrome metabolico, obesidad, diabetes, transtornos del snc, esquizofrenia, alzheimer, dependencia al alcohol y a la nicotina. | |
| RS51669B (en) | NEW DRUG COMBINATIONS AS ANTIDEPRESSIVE | |
| JP2009542820A5 (es) | ||
| FR2912057B1 (fr) | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine | |
| UY29778A1 (es) | Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen. | |
| AR045314A1 (es) | Composiciones farmaceuticas de analepticos y antidepresivos | |
| RU2009101146A (ru) | Лечение ожирения антагонистами мускаринового рецептора м1 | |
| PE20090639A1 (es) | Formas polimorficas de (s)-2-((4-benzofuranil)carbonilaminometil)-1-((4-(2-metil-5-(4-fluorofenil))tiazolil)carbonil)piperidina | |
| RU2011109649A (ru) | Фармацевтическая композиция для профилактики и лечения депрессивных состояний | |
| PE20060463A1 (es) | Combinacion de derivados de n-(indolcarbonil-)piperazina e inhibidores de la recaptacion de serotonina |